Video

Aaron Lyss Outlines Lessons Learned From Data Analytics

In each performance period of the Oncology Care Model for which we've received data, we've seen different aspects of care that we can improve upon in the following 6 months, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.

In each performance period of the Oncology Care Model for which we've received data, we've seen different aspects of care that we can improve upon in the following 6 months, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.

Transcript:

Looking ahead, what are the unmet needs for the practice that could be assisted through a change in government policy?

I think the most critical aspect of government policy that can be addressed through alternative payment models is the payment schema supporting the transition from the fee-for-service environment to the value-based payment environment.

How do you use any lessons learned from data analytics to make any pivots or shifts in strategy?

I think in each performance period of the model for which we've received data, we've seen different aspects of care delivery that we can improve and focus on for the following 6 months. In several instances, this has had to do with the populations of patients in the specific types of cancers that we see in our data as opportunities to improve care delivery.

Related Videos
Roberto Salgado, MD.
Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson chair in preventative cardiology, Tulane University School of Medicine
Screenshot of an interview with Shaun P. McKenzie, MD
Hans Lee, MD
Don M. Benson, MD, PhD, James Cancer Hospital
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Robin Glasco, MBA
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Hans Lee, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo